PCTC
BMY.RT

Perkins Coie Trust Company’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Perkins Coie Trust Company’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74
Closed – – 255
2020
Q4 		$0 Sell
74
-110
-60% -$234 ﹤0.01% 256
2020
Q3 		$0 Sell
184
-80
-30% -$228 ﹤0.01% 302
2020
Q2 		$1K Hold
264
– – ﹤0.01% 290
2020
Q1 		$1K Hold
264
– – ﹤0.01% 329
2019
Q4 		$1K Buy
+264
New +$687 ﹤0.01% 296

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Perkins Coie Trust Company's BMY.RT Position: Q1 2021 in Review

Perkins Coie Trust Company sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 74 shares.

Perkins Coie Trust Company first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Perkins Coie Trust Company reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Perkins Coie Trust Company sold 74 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Perkins Coie Trust Company first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Perkins Coie Trust Company's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Perkins Coie Trust Company's 13F filing for Q1 2021, filed 13 Apr 2021.